Zenith Announces Extension of its Filing Calendar Based on Continuous Disclosure Exemption
26 août 2020 18h00 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces that it intends to rely on blanket exemptions issued by provincial securities...
Zenith Epigenetics Advances ZEN-3694 in Multiple Cancer Programs
29 juil. 2020 08h00 HE
|
Zenith Capital Corp.
CALGARY, Alberta, July 29, 2020 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announced today significant clinical advances of ZEN-3694, the Company’s lead therapeutic...
Zenith Announces Corporate Update Conference Call & Webcast on June 18, 2020 and US$5 Million Equity Investment
16 juin 2020 07h00 HE
|
Zenith Capital Corp.
CALGARY, Alberta, June 16, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces it will be hosting a corporate update via conference call and webcast on...
Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
07 janv. 2020 08h30 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announced receipt of a US$5 million milestone payment, less applicable taxes, from Newsoara...
Zenith Epigenetics Announces Clinical Advancement of ZEN-3694
19 déc. 2019 08h58 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announced today the significant clinical advances of ZEN-3694, the Company’s lead compound...
Zenith Announces Voting Results from the 2019 Annual and Special Meeting of Shareholders
31 oct. 2019 19h36 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual and special meeting of shareholders held earlier today, Zenith...
Zenith Announces Annual and Special Meeting of Shareholders
22 août 2019 17h24 HE
|
Zenith Capital Corp.
CALGARY, Alberta, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith”) announced today that its Annual and Special Meeting of Shareholders (the “Meeting”) is to be held Thursday,...
Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
06 août 2019 08h30 HE
|
Zenith Capital Corp.
This press release is not for dissemination in the United States or through US newswire services CALGARY, Alberta, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith”) announced today...
Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
27 juin 2019 08h30 HE
|
Zenith Capital Corp.
CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a wholly-owned subsidiary of Zenith Capital Corp., announced today that it has dosed the...
Zenith Epigenetics Announces U.S. FDA Clearance of Investigational New Drug Application for ZEN-3694 in TNBC Program
18 mars 2019 09h00 HE
|
Zenith Capital Corp.
Pfizer / Zenith TNBC program collaboration on target to dose first patient in April 2019 Phase 2 mCRPC program and clinical data to be presented at AACR CALGARY, Alberta, March 18, 2019 (GLOBE...